Marc Ferrer

1.4k total citations
69 papers, 948 citations indexed

About

Marc Ferrer is a scholar working on Clinical Psychology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marc Ferrer has authored 69 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Clinical Psychology, 20 papers in Psychiatry and Mental health and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marc Ferrer's work include Personality Disorders and Psychopathology (37 papers), Mental Health and Psychiatry (16 papers) and Attention Deficit Hyperactivity Disorder (11 papers). Marc Ferrer is often cited by papers focused on Personality Disorders and Psychopathology (37 papers), Mental Health and Psychiatry (16 papers) and Attention Deficit Hyperactivity Disorder (11 papers). Marc Ferrer collaborates with scholars based in Spain, United States and Australia. Marc Ferrer's co-authors include Miguel Casas, Natàlia Calvo, Óscar Andión, Josep Antoni Ramos‐Quiroga, Sergi Valero, Joaquim Soler, Juan Carlos Pascual, Rafael Torrúbia, Fernando Gutiérrez and Víctor Pérez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Marc Ferrer

65 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Ferrer Spain	18	619	292	172	85	77	69	948
Juha T. Karvonen Finland	14	485 0.8×	553 1.9×	97 0.6×	83 1.0×	41 0.5×	24	1.0k
Birgit Egedal Bennedsen Denmark	14	297 0.5×	248 0.8×	88 0.5×	87 1.0×	27 0.4×	18	769
Svein Blomhoff Norway	13	323 0.5×	207 0.7×	58 0.3×	83 1.0×	31 0.4×	26	798
Zvi Zemishlany Israel	17	487 0.8×	677 2.3×	75 0.4×	89 1.0×	12 0.2×	33	1.2k
T. F. McNeil Sweden	12	192 0.3×	339 1.2×	69 0.4×	81 1.0×	71 0.9×	20	805
Aslıhan Polat Türkiye	16	513 0.8×	225 0.8×	54 0.3×	117 1.4×	15 0.2×	49	914
Christopher B. Harte United States	14	241 0.4×	268 0.9×	26 0.2×	26 0.3×	71 0.9×	26	579
M. W. Hengeveld Netherlands	15	170 0.3×	334 1.1×	71 0.4×	87 1.0×	23 0.3×	24	617
R. Pollice Italy	17	368 0.6×	459 1.6×	168 1.0×	155 1.8×	16 0.2×	45	844
Birgitte Boye Norway	17	199 0.3×	287 1.0×	31 0.2×	113 1.3×	14 0.2×	25	770

Countries citing papers authored by Marc Ferrer

Since Specialization

Citations

This map shows the geographic impact of Marc Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Ferrer more than expected).

Fields of papers citing papers by Marc Ferrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Ferrer. The network helps show where Marc Ferrer may publish in the future.

Co-authorship network of co-authors of Marc Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Ferrer. A scholar is included among the top collaborators of Marc Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Ferrer. Marc Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrer, Marc, Vanesa Richarte, Laura Gisbert, et al.. (2025). REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disorders. Psychiatry and Clinical Neurosciences. 79(5). 257–265. 1 indexed citations

Ropacki, Michael T., Ronald Brenner, Michael R. Liebowitz, et al.. (2024). Topline Results: a double-blind, randomized placebo-controlled, adaptive phase IIb trial to assess vafidemstat’s efficacy in treating borderline personality disorder. Neuroscience Applied. 3. 105120–105120. 1 indexed citations

Calvo, Natàlia, et al.. (2024). Childhood maltreatment and non-suicidal self-injury in adolescent population: A systematic review and meta-analysis. Child Abuse & Neglect. 157. 107048–107048. 10 indexed citations

Arteaga-Henríquez, Gara, Carmen Schiweck, Alejandro Arias Vásquez, et al.. (2024). Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, “basket” trial. Brain Behavior and Immunity. 120. 360–371. 5 indexed citations

Salgado‐Pineda, Pilar, Marc Ferrer, Natàlia Calvo, et al.. (2024). Brain Functional Correlates of Recall of Life Events in Medication-Naïve Adolescents with Borderline Personality Disorder. Neuropsychobiology. 83(1). 49–60. 1 indexed citations

Ferrer, Marc, María Soler Artigas, Christian Fadeuilhe, et al.. (2022). Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time. Clinical Psychopharmacology and Neuroscience. 20(3). 482–490. 1 indexed citations

Calvo, Natàlia, et al.. (2022). Psychotherapeutic interventions specifically developed for NSSI in adolescence: A systematic review. European Neuropsychopharmacology. 58. 86–98. 28 indexed citations

Gutiérrez, Fernando, Josep M. Peri, Miguel Gárriz, et al.. (2021). Integration of the ICD-11 and DSM-5 Dimensional Systems for Personality Disorders Into a Unified Taxonomy With Non-overlapping Traits. Frontiers in Psychiatry. 12. 591934–591934. 11 indexed citations

Ferrer, Marc, et al.. (2021). Child and adolescent depression and other mental health issues during lockdown and SARS-CoV-2/COVID-19 pandemic: A survey in school setting. SHILAP Revista de lepidopterología. 96(1). 61–64. 4 indexed citations

10.

García‐García, Cosme, Ferran Rueda, Sílvia Pérez-Fernández, et al.. (2018). Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the “Codi IAM” Multicenter Registry). The American Journal of Cardiology. 122(4). 529–536. 12 indexed citations

11.

Cediel, Germán, Ferran Rueda, Claus Oxvig, et al.. (2018). Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovascular Diabetology. 17(1). 63–63. 15 indexed citations

12.

Barral, Carmen, Laia Rodríguez-Cintas, Lara Grau‐López, et al.. (2017). Substance-induced psychotic symptoms in Borderline Personality Disorder among substance use disorder samples in Spain. Psychiatry Research. 260. 313–317. 4 indexed citations

13.

Ferrer, Marc, Óscar Andión, Natàlia Calvo, et al.. (2015). Regional analysis of health service utilisation by persons with borderline personality disorders: implications for evidence-informed policy.. PubMed. 18(1). 17–25. 2 indexed citations

14.

Martín‐Blanco, Ana, Marc Ferrer, Joaquim Soler, et al.. (2014). Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. Journal of Psychiatric Research. 57. 34–40. 101 indexed citations

15.

Andión, Óscar, Marc Ferrer, Josep Lluís Matalí, et al.. (2012). Effectiveness of combined individual and group dialectical behavior therapy compared to only individual dialectical behavior therapy: A preliminary study.. Psychotherapy. 49(2). 241–250. 17 indexed citations

16.

Corominas, M., Josep Antoni Ramos‐Quiroga, Marc Ferrer, et al.. (2012). Cortisol responses in children and adults with attention deficit hyperactivity disorder (ADHD): a possible marker of inhibition deficits. ADHD Attention Deficit and Hyperactivity Disorders. 4(2). 63–75. 28 indexed citations

17.

Aragonès, Enric, et al.. (2012). Registered prevalence of borderline personality disorder in primary care databases. Gaceta Sanitaria. 27(2). 171–174. 27 indexed citations

18.

Andión, Óscar, Marc Ferrer, Natàlia Calvo, et al.. (2011). Confirmatory Factor Analysis of Borderline Personality Disorder symptoms based on two different interviews: The Structured Clinical Interview for DSM-IV Axis II Disorder and the Revised Diagnostic Interview for Borderlines. Psychiatry Research. 190(2-3). 304–308. 19 indexed citations

19.

Ramos‐Quiroga, Josep Antoni, et al.. (2009). Aproximación clínica a la comorbilidad entre el Trastorno por Déficit de Atención con Hiperactividad y el Trastorno Límite de Personalidad en adultos. Dialnet (Universidad de la Rioja). 8(35). 41–49. 1 indexed citations

20.

Ferrer, Marc, et al.. (2004). Comparación de la densidad de receptores D2 estriatales en primeros episodios psicóticos e n relacion al consumo de cannabis.. 31(5). 244–248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact